A single-centre, observational, retrospective, real-life study evaluating adalimumab biosimilar ABP 501 in the treatment of plaque-type psoriasis and psoriatic arthritis in originator-naïve patients and in patients undergoing non-medical switch from originator.

Giunta, A; Zangrilli, A; Bavetta, M; Manfreda, V; Pensa, C; Bianchi, L

Giunta, A; Zangrilli, A; Bavetta, M; Manfreda, V; Pensa, C; Bianchi, L.

Afiliación

Giunta A; Department of Dermatology, University of Rome Tor Vergata, Rome, Italy.
Zangrilli A; Department of Dermatology, University of Rome Tor Vergata, Rome, Italy.
Bavetta M; Department of Dermatology, University of Rome Tor Vergata, Rome, Italy.
Manfreda V; Department of Dermatology, University of Rome Tor Vergata, Rome, Italy.
Pensa C; Department of Dermatology, University of Rome Tor Vergata, Rome, Italy.
Bianchi L; Department of Dermatology, University of Rome Tor Vergata, Rome, Italy.

Curr Med Res Opin ; 37(7): 1099-1102, 2021 07.

Article en En | MEDLINE | ID: mdl-34011212

Asunto(s)

Artritis Psoriásica; Biosimilares Farmacéuticos; Psoriasis; Adalimumab/uso terapéutico; Artritis Psoriásica/tratamiento farmacológico; Biosimilares Farmacéuticos/uso terapéutico; Sustitución de Medicamentos; Humanos; Psoriasis/tratamiento farmacológico; Estudios Retrospectivos; Resultado del Tratamiento

Palabras clave

ABP501; Psoriasis; adalimumab; psoriatic arthritis; treatment

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Psoriasis / Artritis Psoriásica / Biosimilares Farmacéuticos Tipo de estudio: Observational_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Curr Med Res Opin Año: 2021 Tipo del documento: Article País de afiliación: Italia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google